UnknownNCT04718792
Psilocybin for Treatment of Addiction: a Feasibility Study
Medication studyAges 20–70Denmark
Understand this study
Who could participate?
Listed age limits: 20 years to 70 years.
- Listed locations
- CopenhagenSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 9, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 10
- Sponsor
- Anders Fink-Jensen, MD, DMSci
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- From 20 Years to 70 Years
- Official registry ID
- NCT04718792
- Official title
Show the full official title
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Copenhagen
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Anders Fink-Jensen, MD, DMSci.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 20 years to 70 years.
